Hinge Health initially aimed to sell nearly 14 million shares in a $28-$32 range, with final pricing set at the higher end of the range. With some 8.5 million shares sold by the business, gross process from the offering are pegged at $272 million.

Hinge Health today announced the pricing of its initial public offering of an aggregate 13,666,000 shares of its Class A common stock, 8,522,528 of which

Recent health news highlights a U.S. report linking childhood diseases to processed food and chemicals, Hinge Health's successful IPO, and Novo Nordisk's discounted drug offering. Other stories include Moderna's vaccine withdrawal,

As Hinge Health goes public, CEO Dan Perez tells STAT the goal is to automate physical therapy in any way it can.

Initial public offerings from Hinge Health Inc. and MNTN Inc. both priced at the top of their estimated ranges in a bullish sign for the two deals, as the market for initial public offerings continues to gear up after an absence of deals in recent weeks.